Table 2. Details and allele frequencies of detected variants and mutations with a significant relation to low stress resilience.

No.	Gene	SNP number	Nucleotide substitution	Functional Consequence	Number of persons with minor allele in group A	Number of persons with minor allele in group B	Number of persons with minor allele in group C	Number of persons with minor allele in group D
1	DRD1	rs548677242	C/T	Glu ⇒ Lys	57(15%)	76(60%)	32(13%)	45(39%)
2	DRD1	rs779186397	C/T	Arg ⇒ Lys	34(9%)	76(60%)	38(16%)	76(66%)
3	DRD2	rs1076560	A/C	Intron variant	23(6%)	68(55%)	43(18%)	58(49.5%)
4	DRD2	Novel mutation	T/C	Promoter	1(0.25%)	7(5.6%)	1(0.41%)	3(2.5%)
5	DRD3	rs6280	C/T	Ser⇒ Gly	43(11%)	57(46%)	30 (12%)	22(19%)
6	DRD4	rs1800955	C/T	Promoter	16(4%)	59(48%)	14(6%)	59(50%)
7	DRD5	rs2867383	A/G	intron variant	19(5%)	80(65%)	17(7%)	33(28%)
8	DBH	rs2283123	C/T	intron variant	31(8%)	73(59%)	5(2%)	58(50%)
9	DBH	rs1611115	C/T	Upstream variant	70(18%)	86(69%)	48(20%)	71(61%)
10	COMT	rs165599	A/G	Intron variant	42(11%)	66(53%)	18(7%)	73(62%)
11	COMT	rs4680	G/A	Val⇒ Met	12(3%)	86(70%)	10(4%)	46(39%)
12	COMT	Novel mutation	G/A	Promoter	1(0.25%)	6(4.8%)	1(0.41%)	4(3.4%)
13	COMT	Novel mutation	G/T	Promoter	2(0.5%)	13(10%)	1(0.41%)	8(7%)
14	MAOA	rs5906957	A/G	Intron variant	47(12%)	57(45%)	30(12.5%)	34(29%)
15	BDNF	rs6265	A/G	Val⇒ Met	16(4%)	68(55%)	14(6%)	61(52%)
16	BDNF	rs146354977	C/T	Val⇒ Met	27(7%)	55(44%)	22(9%)	56(48%)
17	BDNF	rs760902255	T/C	Asn⇒ Asn	31(8%)	58(48%)	9(4%)	53(45%)
18	GDNF	rs752541985	C/T	Lys ⇒ Arg	16(4%)	88(71%)	17(7%)	82(70%)
19	GDNF	Novel mutation	A/T	Lys ⇒Asn	1(0.25%)	11(6.4%)	1(0.41%)	3(2.5%)
20	5-HTT	Novel mutation	C/G	Arg ⇒ Pro	2(0.5%)	14(10.8%)	1(0.41%)	8(7%)
21	5-HTT	Novel mutation	C/G	Ala⇒ Pro	1(0.25%)	10(8%)	1(0.41%)	5(4.2%)
22	5-HTT	rs25531	A/G	Intron variant	32(8%)	59(48%)	16(7%)	72(62%)
23	DAT	rs431905515	C/T	Leu ⇒ Pro	16(4%)	98(79%)	19(8%)	83(71%)
24	DAT	rs431905516	C/T	Arg ⇒ Trp	17(4%)	89(72%)	26(11%)	80(69%)

mut: mutation, SNP: single nucleotide polymorphism, Chr: chromosome.